Brain Stimulation for Epilepsy
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for epilepsy?
Research shows that electrical stimulation techniques like Functional Electrical Stimulation (FES) and Neuromuscular Electrical Stimulation (NMES) can improve muscle strength and function in conditions such as stroke and spinal cord injuries. While these studies focus on muscle and motor function, they suggest potential benefits of electrical stimulation in neurological conditions, which may be relevant for epilepsy treatment.12345
Is electrical stimulation generally safe for humans?
Research indicates that electrical stimulation, such as peripheral nerve stimulation, is generally considered safe for humans, though specific safety data for chronic use is limited. Studies have reviewed safety aspects like stimulation parameters and charge limitations, especially for applications in the central nervous system.46789
How does electrical stimulation treatment for epilepsy differ from other treatments?
Electrical stimulation for epilepsy is unique because it involves using electrical impulses to target specific areas of the brain or nervous system to reduce seizures, especially when medications or surgery are not effective. Unlike traditional drug treatments, it can be tailored to stimulate the brain at the site of seizure generation or network hubs, offering a more personalized approach.1011121314
What is the purpose of this trial?
This study is designed to identify brain activity associated with good memory in subjects with a chronically implanted RNS® device and to study the effects of therapeutic stimulation for epilepsy on memory. This will be accomplished through analysis of ECoG data collected during memory encoding for short and long-term free recall as well as during navigation tasks.
Research Team
Barbara Jobst, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
Eligibility Criteria
This trial is for adults over 18 with epilepsy who have had an RNS® device implanted for at least 3 months. Participants must be able to consent and complete tasks as judged by the lead researcher.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo therapeutic stimulation for epilepsy and memory tasks using the RNS® Neurostimulator
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Electrical Stimulation
Electrical Stimulation is already approved in United States, European Union, Canada for the following indications:
- Pain relief
- Muscle strengthening
- Rehabilitation after injury or surgery
- Neurological disorders
- Wound healing
- Pain management
- Muscle rehabilitation
- Neurological conditions
- Wound care
- Chronic pain
- Muscle atrophy
- Neurological rehabilitation
- Wound healing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Barbara Jobst
Lead Sponsor
NeuroPace
Industry Sponsor